January 19, 2014

NAI was commissioned by eyeforpharma to write the whitepaper, Oncology Market Access: Trends, Challenges, and Strategies for U.S. Pharma. One of eyeforpharma’s most downloaded whitepapers, the paper was produced in coordination with the upcoming conference, Oncology USA Summit 2014, in Boston March 25-26.

Relying on a synthesis of recent actions by healthcare stakeholders and illuminated by interviews with payers across the country, the paper explores the impact of regulatory shifts and healthcare consolidation on oncology market access, as well as the increasing use of payers’ tools to control drug costs in the U.S.

Authors Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Michael Kuchenreuther, Ph.D., Research Analyst, open an important window into the changing dynamics of the U.S oncology landscape and the key drivers and barriers associated with current and future market trends.